Intersect ENT, Inc.
Intersect ENT, Inc. is listed today as Intersect Ent: market value, financials and filings are on its company page.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2013 | $21 M | No. 2 | $10 to $50 million | equity | SEC | |
| Oct 2010 | $31 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Intersect ENT, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2013).
SEC Form D · Mar 2013
The industry group it chose in its notices: Other Health Care.
SEC Form D · Mar 2013
That is all the official record says: Intersect ENT, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Intersect ENT, Inc. are on record.
Investors#
14 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Amy Wolbeck | Person | not stated | not stated | Held Series D preferred stock (Form 3, 2014) | SEC Form 3 |
| Frederic H. Moll | Person | not stated | not stated | Held Series A, B, C and D preferred stock, director (Form 3, 2014) | SEC Form 3 |
| Kleiner Perkins Caufield & Byers XI-A LP | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Kleiner Perkins Caufield & Byers XI B LP | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| KPCB XI Associates, LLC | Other | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Norwest Venture Partners XII, LP | Venture capital | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Norwest Venture Partners XI, LP | Venture capital | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Pinto Technology Ventures GP II, L.P. | Venture capital | not stated | not stated | Held Series B, C and D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Pinto TV GP CO LLC | Other | not stated | not stated | Held Series B, C and D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Presidio Management Group IX, L.L.C. | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| PTV Sciences II L.P. | Fund or asset manager | not stated | not stated | Held Series B, C and D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Richard E. Kaufman | Person | not stated | not stated | Held Series D preferred stock (Form 3, 2014) | SEC Form 3 |
| Robert H. Binney Jr. | Person | not stated | not stated | Held Series D preferred stock (Form 3, 2014) | SEC Form 3 |
| U S Venture Partners IX L.P. | Venture capital | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 34 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Lisa D. Earnhardt | Executive officer | Mar 2013 |
| Monika A. De Martini | Executive officer | Mar 2013 |
| Richard E. Kaufman | Executive officer | Mar 2013 |
| Casey M. Tansey | Director | Mar 2013 |
| Casper H. de Clercq | Director | Mar 2013 |
| Dana G. Mead, Jr. | Director | Mar 2013 |
| Frederic H. Moll | Director | Mar 2013 |
| Lisa D. Earnhardt | Director | Mar 2013 |
| Mark A. Fletcher | Director | Mar 2013 |
| Rick M. Anderson | Director | Mar 2013 |
| Evan S. Melrose | Director | Sep 2011 |
About
Health care equipment company, subsidiary of Medtronic.